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Abstract
Surveillance for highly pathogenic avian influenza viruses (HPAIV) in wild birds is
logistically demanding due to the very low rates of virus detection. Serological
approaches may be more cost effective as they require smaller sample sizes to
identify exposed populations. We hypothesized that antigenic differences between
classical Eurasian H5 subtype viruses (which have low pathogenicity in chickens)
and H5N1 viruses of the Goose/Guangdong/96 H5 lineage (which are HPAIV) may
be used to differentiate populations where HPAIVs have been circulating, from
those where they have not. To test this we performed hemagglutination inhibition
assays to compare the reactivity of serum samples from wild birds in Mongolia
(where HPAIV has been circulating, n51,832) and Europe (where HPAIV has been
rare or absent, n5497) to a panel of reference viruses including classical Eurasian
H5 (of low pathogenicity), and five HPAIV H5N1 antigens of the Asian lineage A/
Goose/Guangdong/1/96. Antibody titres were detected against at least one of the
test antigens for 182 Mongolian serum samples (total seroprevalence of 0.10,
n51,832, 95% adjusted Wald confidence limits of 0.09–0.11) and 25 of the
European sera tested (total seroprevalence of 0.05, n5497, 95% adjusted Wald
confidence limits of 0.03–0.07). A bias in antibody titres to HPAIV antigens was
found in the Mongolian sample set (22/182) that was absent in the European sera
(0/25). Although the interpretation of serological data from wild birds is complicated
by the possibility of exposure to multiple strains, and variability in the timing of
exposure, these findings suggest that a proportion of the Mongolian population had
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survived exposure to HPAIV, and that serological assays may enhance the
targeting of traditional HPAIV surveillance toward populations where isolation of
HPAIV is more likely.
Introduction
Since its emergence in 1997, a highly pathogenic strain of avian influenza virus
(HPAIV) subtype H5N1 has affected 64 countries and is now enzootic in parts of
Asia and Africa [1]. Outbreaks have led to heavy losses of domestic poultry, and
although absolute numbers of human infections remain relatively small, concerns
persist that minor genetic mutations could produce a pandemic virus [2, 3]. While
the impact of HPAIV H5N1 has been greatest within the domestic poultry sector,
the role of wild birds in viral persistence and spread remains unresolved [4]. Much
of our understanding arises from studies of birds that are clinically affected or
dead [5–7], but attempts to study the virus in the more epidemiologically relevant
live birds has proven challenging.
Detection of HPAIV antigen in live wild birds is logistically demanding. Given
the transient nature of influenza virus infections (with less than ten days of viral
shedding [8, 9]), very large sample sizes are required to attain acceptable levels of
detection probability [10]. This is further compounded by variation in species
susceptibility to HPAIV infection [8], and potential for spatial and temporal
fluctuations in prevalence [10, 11]. Successful surveillance for HPAIV in wild bird
populations therefore requires that efforts be directed at the correct species at the
correct place and time, and be of sufficient scale to detect circulating virus. For
these reasons it is perhaps unsurprising that antigen-directed surveillance
techniques have been largely unsuccessful in detecting HPAIV in free-ranging wild
birds.
Serological approaches to HPAIV surveillance may represent a more cost
effective strategy, but must overcome a number of challenges. Antibodies to the
surface glycoprotein hemagglutinin (HA) can be measured using several
techniques (such as hemagglutinin inhibition [HI], and microneutralisation
assays). These antibodies persist for prolonged periods enabling assessment of
seroprevalence based on a relatively modest sample size [12]. Therefore, while the
per-sample cost of serological surveillance may be high, the potential to draw
conclusions from a smaller sample sizes could reduce overall costs of surveillance
programs. However, individual tests cannot differentiate between HA antibodies
arising from infections with high versus low pathogenic avian influenza viruses
(LPAIV) and remains an important obstacle to their use in HPAIV surveillance.
Unlike most influenza viruses in wild birds, highly pathogenic strains of the H5
subtype are genetically highly variable [13], due to accumulated mutations in the
HA gene and corresponding amino acid substitutions in the HA protein that give
rise to the phenomenon called ‘antigenic drift’ [14]. Assays such as HI that
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measure the reactivity between antibodies and antigens have shown that
genetically distinct viruses may also differ antigenically [15, 16]. The objective of
this study is to test the hypothesis that low pathogenic classical Eurasian H5
viruses (CE-LP-H5) and highly pathogenic H5 viruses from the Asian lineage A/
Goose/Guangdong/1/96 (GG-HP-H5) differ antigenically, and that this may be
used to differentiate wild bird populations where HPAIVs have been circulating
(e.g. Mongolia, S1 and S2 Figures), from those where they have not (e.g. Europe,
S1 and S3 Figures). To test this we used HI assays and titre comparison to assess
the viability of serosurveillance as a means of identifying wild bird populations
that have been exposed to HPAIV.
Materials and Methods
Sample selection
Comparative sets of serum samples were selected to represent geographic regions
with a history of HPAIV outbreaks in wild birds (Mongolia), and areas where no
wild bird outbreaks of HPAIV had been recorded (Norway and The Netherlands,
referred collectively as Europe). As far as possible sample sets were matched
taxonomically, with a bias toward species within the order Anseriformes that are
believed to represent the principal reservoir of all influenza viruses [17].
A total of eight HPAIV H5N1 outbreaks have been reported in Mongolia
between 2005 and 2013 [11]. Using the World Health Organization classification
system for the nomenclature of HPAIV H5N1 [18], these outbreaks included four
involving viruses from clade 2.2 at two sites in the aimags (provinces) of Bulgan
and Khovsgol during 2005 and 2006, and clade 2.3.2.1 at four sites in Arkhangai,
Khovsgol and Sukhbaatar aimags during 2009 and 2010 [11]. Serum samples were
collected from wild waterbirds in Arkhangai, Bulgan and Khovsgol between July
2008 and August 2009, and included birds captured during HPAIV outbreaks at
Erhel Nuur (July 2009), and Doroo Tsagaan Nuur (August 2009) [11].
Samples representing Europe were collected in the Netherlands and Norway
(Spitsbergen) between July 2005 and February 2012 (hereafter referred to as the
European sample set). There have been no cases of HPAIV H5N1 recorded in
either country, and although wild bird outbreaks have occurred elsewhere in
Europe since October 2005, they have been infrequent since 2006 [19].
Sera were prescreened using a commercially available bELISA (FlockCheck AI
MultiS-Screen Antibody Test Kit, IDEXX Laboratories, Westbrook, Maine, USA)
to identify samples with antibodies to influenza virus nucleoprotein (NP)
indicating exposure to influenza A virus following the manufacturer’s instruc-
tions. Samples testing positive for influenza A antibodies were then selected for HI
analysis. These samples were all collected from live birds showing no signs of
disease, with the exception of three clinically ill ruddy shelducks (Tadorna
ferruginea) from Mongolia from which HPAIV H5N1 was diagnosed [11], and
one tundra swan (Cygnus columbianus) with bacterial septicaemia but no HPAIV,
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which was sampled at Erhel Nuur in Mongolia on 12 July 2009, 18 days before
HPAIV was isolated from another bird at this site.
Hemagglutinin inhibition
Test sera underwent HI assays against a panel of six standard influenza antigens
using published methods [20]. Briefly, serum samples were incubated for 16 hours
at 37 C˚ with the receptor-destroying enzyme of Vibrio cholera to remove non-
specific inhibitors of hemagglutination activity, followed by inactivation for one
hour at 56 C˚. Two-fold serial dilutions of test sera with a starting titre of 1:20 were
prepared using phosphate-buffered saline in U-bottom 96 well microtiter plates.
These were incubated at 37 C˚ for 30 minutes with four hemagglutinating units of
one virus from the standard antigen panel. Dilutions were then incubated for one
hour at 4 C˚ with a 1% solution of turkey erythrocytes. Hemagglutination patterns
were then read in duplicate. The virus panel included six 6:2 recombinant viruses
based on a PR8 backbone, with the HA and NA of diverse H5 strains including
CE-LP-H5, and representatives of the Asian lineage GG-HP-H5, including viruses
from H5N1 clade 0, 1, 2.1, 2.2, and 2.3 (Table 1). The sequence of the HA genes
was modified to remove the multi-basic cleavage site to enable study within
biosafety level 2 laboratories.
Negative controls (based on serum incubated without virus) were used to
measure non-specific hemagglutination by each serum sample, and used as a
minimum sensitivity cut-off for the assay. Serum derived from experimental
exposure studies that challenged wild bird test subjects with HPAIV strains (the
birds were negative for antibodies to influenza A virus at the time of exposure)
were used as positive controls ([21–26] Table 2).
Ethics statement
For Mongolia, bird capture and handling permits were issued by the Mongolian
Ministry of Nature, the Environment and Tourism following approval of
protocols by the Institute of Biology at the Mongolian Academy of Sciences, with
additional approval from the University of Minnesota, Institutional Animal Care
and Use Committee (Protocol 1006A84613). Samples from European wild birds
were collected under permits 122-11-31, and 122-07-09 from the National
Institute of Public Health and the Environment in Bilthoven, issued by Stichting
DEC Consult (for the capture and collection of samples from wild birds in the
Netherlands), and permit 201000149 obtained through the University of
Groningen (for the capture and sampling wild birds in Norway).
Results
Sample selection
A total of 1,832 serum samples were available from surveys in Mongolia, of which
479 were found to be positive for antibodies to NP using a blocking ELISA
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(bELISA) and selected for HI analysis. A full account of the bELISA results from
Mongolia have been published elsewhere [27]. A total of 497 sera were available
from surveys conducted in Europe. Of these 200 were selected for HI analysis
based on the presence of antibodies to influenza A virus.
Hemagglutinin inhibition assays
Serum samples with antibodies against influenza A virus NP underwent HI
analyses against a panel of six H5 influenza virus strains including CE-LP-H5, and
five GG-HP-H5 representatives including viruses from clade 0, 1, 2.1, 2.2, and 2.3
(Table 1). Titres are summarized in Table 3 and are provided in full in S1, S2 and
Table 1. Recombinant virus strains.
Clade Strain name Abbreviation
Classic A/mallard/Netherlands/3/99(H5N2) NL99
Clade 0 A/HongKong/156/1997(H5N1) HK97
Clade 1 A/Viet Nam/1194/2004(H5N1) VN04
Clade 2.1 A/Indonesia/5/2005(H5N1) ID05
Clade 2.2 A/Turkey/Turkey/1/2005(H5N1) TU05
Clade 2.3 A/Anhui/1/2005(H5N1) AN05
Original virus strains for the hemaglutinin and neuraminidase antigens used in the standard panel of recombinant influenza A viruses used in
hemagglutination inhibition assays.
doi:10.1371/journal.pone.0113569.t001
Table 2. Positive control sera.
Species of test subject Exposure strain Exposure clade Reference
Herring gull A/DK/AY/AVL-1/2001(H5N1) 1 (21)
Herring gull A/DK/AY/AVL-1/2001(H5N1) 1 (21)
Common pochard A/turkey/Turkey/1/2005(H5N1) 2.2 (22)
Tufted duck A/turkey/Turkey/1/2005(H5N1) 2.2 (22)
Tufted duck A/turkey/Turkey/1/2005(H5N1) 2.2 (22)
Eurasian wigeon A/turkey/Turkey/1/2005(H5N1) 2.2 (22)
Dunlin A/WS/MN/244/2005(H5N1) 2.2 (23)
Dunlin A/WS/MN/244/2005(H5N1) 2.2 (23)
Dunlin A/WS/MN/244/2005(H5N1) 2.2 (23)
Greylag goose A/CK/Korea/IS/2006(H5N1) 2.2 (24)
Greylag goose A/CK/Korea/IS/2006(H5N1) 2.2 (24)
Mandarin duck A/CK/Korea/IS/2006(H5N1) 2.2 (24)
Bar-headed goose A/WS/MN/244/2005(H5N1) 2.2 (25)
Bar-headed goose A/RS/MN/X63/2009(H5N1) 2.3 (26)
Bar-headed goose A/RS/MN/X63/2009(H5N1) 2.3 (26)
Details of positive control sera from wild bird test subjects that were experimentally exposed to strains of highly pathogenic avian influenza virus of the Asian
lineage A/Goose/Guangdong/1/96, H5N1. Viral strain names include the acronyms: WS5whooper swan, RS5ruddy shelduck, DK5duck, CK5chicken,
AY5Anyang, MN5Mongolia.
doi:10.1371/journal.pone.0113569.t002
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S3 Tables. Of the 479 Mongolian serum samples tested, 182 were found to
contain detectable antibody titres to one or more of the test antigens (total
seroprevalence of 0.10, n51,832, 95% adjusted Wald confidence limits of 0.09–
0.11) while HI titres were found against at least one antigen for 25 of the 200
European sera tested (total seroprevalence of 0.05, n5497, 95% adjusted Wald
confidence limits of 0.03–0.07), and 14 of 15 positive control sera. The HA
antigen HK97 was found to bind most widely with test sera, with binding
antibody titres found in 171/479 of the Mongolian samples and 25/25 of the
European samples.
HA antibody titres in Mongolia and Europe were generally low, with only
27.3% of Mongolian and 9.0% of European samples with measurable titres higher
than 1:20. The geometric mean value (GMV) was calculated for all titres obtained
for each sample. The five sera with the highest GMVs were all from Mongolia, of
which three were from birds sampled at lakes where outbreaks were ongoing, and
one was the tundra swan sampled at Erhel Nuur in early July 2009, 18 days before
HPAIV H5N1 was detected at this site.
Table 3. Summary of hemagglutinin inhibition (HI) titres.
Sample set
Titre
(Log2) No HI titre
recordedAntigen 0 1 2 3 4 5 6 7 8 9 10 11 12
Mongolia NL99
[Classic]
13 (7) 33 (18) 14 (8) 11 (6) 13 (7) 4 (2) 1 (1) 0 (0) 2 (1) 0 (0) 0 (0) 0 (0) 0 (0) 91 (50)
Europe 0 (0) 9 (36) 2 (8) 4 (16) 1 (4) 0 (0) 4 (16) 1 (4) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 4 (16)
Control 0 (0) 0 (0) 0 (0) 0 (0) 1 (7) 0 (0) 0 (0) 2 (13) 1 (7) 0 (0) 0 (0) 0 (0) 0 (0) 11 (73)
Mongolia HK97 [0] 17 (9) 60 (33) 39 (21) 21 (12) 18 (10) 10 (5) 1 (1) 2 (1) 2 (1) 0 (0) 1 (1) 0 (0) 0 (0) 11 (6)
Europe 5 (20) 7 (28) 4 (16) 2 (8) 4 (16) 2 (8) 1 (4) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Control 3 (20) 1 (7) 2 (13) 2 (13) 2 (13) 0 (0) 1 (7) 0 (0) 0 (0) 2 (13) 0 (0) 1 (7) 0 (0) 1 (7)
Mongolia VN04 [1] 7 (4) 20 (11) 9 (5) 5 (3) 2 (1) 0 (0) 1 (1) 1 (1) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 137 (75)
Europe 0 (0) 1 (4) 1 (4) 3 (12) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 20 (80)
Control 0 (0) 1 (7) 0 (0) 0 (0) 0 (0) 0 (0) 3 (20) 0 (0) 0 (0) 0 (0) 7 (7) 0 (0) 0 (0) 10 (67)
Mongolia ID05 [2.1] 7 (4) 20 (11) 10 (5) 8 (4) 7 (4) 2 (1) 2 (1) 0 (0) 1 (1) 0 (0) 0 (0) 0 (0) 0 (0) 125 (69)
Europe 3 (12) 1 (4) 2 (8) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 19 (76)
Control 0 (0) 0 (0) 1 (7) 0 (0) 0 (0) 1 (7) 2 (13) 0 (0) 0 (0) 0 (0) 7 (7) 0 (0) 0 (0) 10 (67)
Mongolia TU05 [2.2] 10 (5) 30 (16) 26 (14) 15 (8) 9 (5) 4 (2) 1 (1) 1 (1) 1 (1) 0 (0) 0 (0) 0 (0) 0 (0) 85 (47)
Europe 2 (8) 3 (12) 4 (16) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 16 (64)
Control 0 (0) 2 (13) 2 (13) 0 (0) 1 (7) 0 (0) 2 (13) 1 (7) 1 (7) 0 (0) 0 (0) 0 (0) 1 (7) 5 (33)
Mongolia AN05 [2.3] 3 (2) 22 (12) 17 (9) 8 (4) 4 (2) 2 (1) 2 (1) 1 (1) 0 (0) 1 (1) 0 (0) 0 (0) 0 (0) 122 (67)
Europe 0 (0) 5 (20) 1 (4) 1 (4) 1 (4) 2 (8) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 15 (60)
Control 0 (0) 1 (7) 1 (7) 1 (7) 0 (0) 1 (7) 0 (0) 1 (7) 1 (7) 0 (0) 0 (0) 1 (7) 8 (53) 0 (0)
Includes serum sample sets from Mongolia (x182), Europe (x25), and a positive control set (x15). Samples underwent an initial log10 dilution, followed by
serial log2 dilutions, with the initial 1:10 equivalent set to 0 on the log2 scale. HI titres were measured for all sera against a panel of standard influenza A virus
H5 antigens, including A/mallard/Netherlands/3/1999(H5N2) (NL99), A/Hong Kong/156/1997(H5N1) (HK97), A/Viet Nam/1194/2004(H5N1) VN04, A/
Indonesia/5/2005(H5N1) (ID05), A/Turkey/Turkey/1/2005(H5N1) (TU05), and A/Anhui/1/2005(H5N1) (AN05). H5 clade designation is given in square
brackets. Number of samples testing positive is indicated at each titre, and expressed as a percentage of each sample set tested in parentheses.
doi:10.1371/journal.pone.0113569.t003
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The Mongolian sample set included serum from three sick ruddy shelducks that
were diagnosed with HPAIV H5N1 (by RT-PCR and virus isolation [11]).
Antibody titres were recorded against two (HK97 and ID05) and all six of the test
antigens for two of these birds (both of which were adults, MN09A-0556 and
MN09A-0969 respectively), while no antibody titres were detected for the third (a
hatch year bird, MN09A-0911).
The measurable antibody titre recorded for the 15 positive control sera varied
widely, with only four samples found to have titres against all six antigens (of
which all were ducks, and all had at least one titre of 1:640 or greater). All of the
remaining positive control sera were obtained from Charadriiformes, geese or
mandarin ducks (Aix galericulata), and only one of these was found to have titres
to more than three of the antigens (a greylag goose [Anser anser], Bird #43, which
recorded titres against four of the antigens, and a maximum of 1:960). Once again
measurable antibodies were recorded most frequently against HK97 (14/15
samples), followed by TU05 (10/15 samples).
Direct comparison of titres
Individual HI tables were examined to determine whether populations in Europe
and Mongolia showed a bias in titres against HPAIVs or LPAIVs. Sera where titres
to GG-HP-H5 antigens (clades 1, 2.1, 2.2 and 2.3) exceeded those for the CE-LP-
H5 antigen were defined as being HPAIV-biased, while those that fell below were
termed LPAIV-biased. Titres to HK97 (clade 0) were excluded from the analysis as
these exceeded all other titres in the majority of sera tested (157/221 Mongolian,
European and positive control sera with antibody titres to H5). Samples where
titres to GG-HP-H5 and CE-LP-H5 antigens were identical, or differed by one
log2 unit or less (the error inherent in the HI assay [28]) were considered to be
ambiguous and lacking in bias. The results of this analysis are presented in
Table 4. All of the European sera with HI titres above the threshold were
considered either LPAIV-biased, or ambiguous. By contrast 22 of the Mongolian
sera were considered HPAIV-biased, 7 as LPAIV-biased, and 153 as ambiguous.
A bootstrap analysis was performed to test whether these findings may be an
artifact of the small number of European samples with antibodies to H5 (n525
samples). It is possible that the lack of HPAIV-biased sera in the European sample
set may have resulted by chance, due to the lower number of sera with antibodies
to H5. To test this, a random sample of 25 sera was selected from the Mongolian
samples to determine whether the HPAIV-bias would be retained when fewer sera
were considered. Samples with an HPAIV-bias were scored +1, those with an
LPAIV-bias scored 21 and a score of 0 was allocated to ambiguous samples. Thus
the sum of individual scores would be .0 for a population that was HPAIV-
biased and ,0 for an LPAIV-bias. This was repeated 10,000 times to generate a
distribution of predictions (Fig. 1). The distribution of predicted scores exceeded
that of the 25 European sera in all cases (as the European sample set contained
more LPAIV-biased samples than the Mongolia sample set), and although 7.6% of
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runs predicted a population that was LPAIV-biased overall, the mean prediction
was distinctly HPAIV-biased with a mean score of 2.01.
Discussion
The theoretical basis for this study relied on a marked difference in the
antigenicity of HP viruses from Classical H5 viruses, of an extent that greatly
exceeded the antigenic variation present within Classical viruses. Prior experi-
ments using ferret antisera raised against four Classical H5 viruses isolated in
Europe, Asia and Africa between 1963 and 2002 found only marginal antigenic
differences across a panel of 12 Classical H5 viruses isolated from domestic and
wild birds between 1959 and 2002 in both Old and New World locations (S4
Table). In contrast, markedly lower titres were measured using this set of ferret
Table 4. Bias in serum titres.
Sample set HPAI-biased LPAI-biased Ambiguous
Mongolia 22 7 153
European - 10 15
Positive control 9 - 5
Summarizing the numbers of serum samples based on the ratio of hemaglutination inhibition (HI) titres to low pathogenic avian influenza virus (LPAIV) and
highly pathogenic avian influenza virus (HPAIV) (H5N1 clades 1, 2.1, 2.2 or 2.3). Sera with titres to LPAIV exceeding the highest titres against HPAIV are
termed ‘LPAIV-biased’, and sera with titres to LPAIV falling below the highest titres against HPAIV antigens are termed ‘HPAIV biased’. Sera for which titres
against LPAIV and HPAIV differ by one log2 unit or less (the error inherent in the HI assay) are termed ‘ambiguous’.
doi:10.1371/journal.pone.0113569.t004
Fig. 1. A histogram illustrating the results of a bootstrap analysis to control for sample size and
determine whether European and Mongolian sample sets differed in their capacity to identify a
population bias toward titres against HPAIV versus LPAIV. The analysis randomly selected 25 serum
samples (equivalent to the number of European sera assessed) from the 182 Mongolian sera. Individual sera
were scored +1 for HPAIV-biased sera,21 for LPAIV-biased sera and 0 for ambiguous sera. The analysis was
repeated 10,000 times and bars represent the frequency of total scores. The vertical dashed line represents
the equivalent score for the European sample set.
doi:10.1371/journal.pone.0113569.g001
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antisera against viruses from the GG-HP-H5 lineage clades examined during the
present study. In common with the sample set from European birds, the ferret
antisera also measured high titres against the GG-HP-H5 lineage Clade 0 virus,
adding support to the decision to omit this virus from the analysis due to its lack
of discriminatory power.
When viewed at a population level, these results highlight several important
differences in the serological profile of wild birds from Mongolia in comparison to
those from Europe. Firstly, while seroprevalence data suggest that wild birds in
Europe experience similar or higher levels of exposure to influenza A viruses than
those in Mongolia, Mongolian birds are twice as likely to be carrying antibodies to
viruses of the H5 subtype (182/1,832 in Mongolia versus 25/497 in Europe), a
difference that is statistically significant (x2511.612, d.f.51, p50.000). When
considered in isolation these results are unable to differentiate between exposures
to LPAIV (represented by CE-LP-H5 virus) from those to HPAIV H5N1
(represented by GG-HP-H5 subtypes). However, by comparing relative HI titres
to CE-LP-H5 and to GG-HP-H5 antigens across the populations a clear difference
is evident, with a proportion of Mongolian sera found with a bias in titres against
HPAIV H5N1 strains that is absent in the sample of European sera. The most
likely explanation for this disparity is that at least a proportion of wild birds in
Mongolia have been exposed to HPAIV H5N1and developed an antibody
response to them, while those in Europe have not.
In Europe, isolation of LPAIV strains of the H5 subtype has been relatively
common [29, 30] and therefore it is not unexpected that antibodies to these
viruses should be found in this population. By contrast, HPAIV H5N1 has not
been recorded in either of the countries where European samples were collected
(the Netherlands and Norway). However, it is important to consider whether
birds could have encountered the virus during their annual migrations to other
countries. Samples from Spitsbergen were predominantly barnacle geese (Branta
leucopsis), which migrate to Scotland (S3 Figure), where only a single case of
HPAIV H5N1 has been recorded [19]. The Dutch samples were dominated by
mallards (Anas platyrhynchos), represented locally by a resident and a migratory
subpopulation, with migrants breeding in northwest Russia, Finland, Sweden and
the Baltic states [31] (S3 Figure). Although outbreaks of HPAIV H5N1 have been
recorded in several states bordering the Baltic Sea [6, 32, 33], these have been
sporadic and infrequent [19]. Therefore, while it is conceivable that mallards
sampled in the Netherlands could have been exposed to HPAIV H5N1 this is
considered relatively unlikely.
The birds represented in the Mongolian sample are more likely to have
encountered H5 viruses of high as well as low pathogenic strains. Low pathogenic
strains of H5 viruses have been isolated in Mongolia in 2001, 2011 and 2013
[34, 35], and there have been eight outbreaks of HPAIV H5N1 recorded in the
country since 2005 [11]. Birds may also have encountered H5 viruses during their
annual movements to and from wintering areas in central and eastern China, and
the Indian subcontinent including large areas where HPAIV H5N1 is enzootic (S1
and S2 Figures).
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On an individual bird level exposure histories are more challenging to interpret.
In most cases antibody titres were relatively low, suggesting that exposures may
have occurred many months or even years earlier. Anseriformes are long lived,
with longevity records of 28, 40 and 24 years for wild individuals of the genera
Cygnus, Anser and Tadorna respectively [36]. Antibody titres might therefore
represent multiple exposures to H5 viruses during their lifetimes, potentially
involving both low and highly pathogenic subtypes. The influence of such
complex histories on the HI profile of individual birds is hard to predict. Indeed,
it should be noted that both of the serum samples with H5 titres from confirmed
HPAIV H5N1 cases were considered to be ambiguous with respect to their titres
to LPAIV and HPAIV strains and showed no bias.
Among the Mongolian samples six species were found to have HPAIV-biased
sera including bar-headed goose (Anser indicus, x12), bean goose (A. fabilis, x1),
swan goose (A. cygnoides, x1), whooper swan (C. cygnus, x3), ruddy shelduck (x4)
and tufted duck (Aythya fuligula, x1). Although HPAIV-biased sera were more
commonly recorded in bar-headed geese (representing 29% of the samples found
to have antibodies to H5 subtypes), this should not imply that the species has been
disproportionately exposed to HPAIV H5N1 in comparison to other birds. Only
7% of bar-headed geese sampled were found to be seropositive for H5 antibodies,
suggesting that repeat exposures may be less likely in this species, resulting in less
complicated HI profiles. By contrast, 26% of adult ruddy shelducks have
antibodies to H5 viruses, suggesting that repeat exposures may be more common,
and thus individual HI profiles are more difficult to interpret.
Several positive control sera did not inhibit hemagglutination by viruses that
were genetically similar to the antigens to which the birds were experimentally
exposed. For instance neither of the bar-headed geese that were inoculated
experimentally with Mongolia/X63/09 (a clade 2.3.2.1 virus) (Bird #81 and Bird
#94) were able to inhibit hemagglutination by AN05 (a clade 2.3 virus) despite
demonstrating titres against other H5 strains. This is consistent with the
observation that some genetic changes may lead to disproportionately large
differences in antigenicity [28]. The HA genes of Mongolia/X63/09 and AN05 are
93.0% identical at the nucleic acid level, and are 94.1% identical in their predicted
amino acid sequence based on a pair-wise distance model. This is of particular
importance in interpreting the HI tables for the Mongolian sera, as Mongolia/
X63/09 was derived from Doroo Tsagaan Nuur in July 2009, at the same location
and period as many of the outbreak samples tested in this study were collected.
However, despite this anomaly the HI patterns of both these positive control sera
were determined to have an HPAIV-bias, and so the impact in the interpretation
of field serum samples may have been limited.
This study represents the first serological evidence that relatively large numbers
of wild birds are likely surviving exposure to HPAIV H5N1. The implication of
this for the spread of HPAIV H5N1 is unclear. Viral challenge that is sufficient to
elicit an immune response need not equate to viral replication and shedding.
Experimental challenge studies have demonstrated high rates of mortality in some
species (such as whooper swans and bar-headed geese [9]), with subclinical
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infection and virus shedding in others (such as ducks [8]). However, these
experimental studies must be interpreted cautiously with respect to the wild
situation where exposure to lower doses of virus may enable birds to mount an
immune response without incurring infection or subsequent viral release. Further
experimental challenge studies have also demonstrated cross-protective immunity
to HPAIV H5N1 in birds exposed to other subtypes [37–39], which may further
enhance the capacity for wild birds to survive HPAIV infection. The protective
capacity of antibodies to H5 and heterosubtypic viruses, and the potential impact
this could have on herd immunity also warrants closer study. Despite the
emergence of two H5N1 clades among wild birds in central Asia, the virus does
not appear to persist in the population indefinitely [11], an eventuality that would
be hastened by an increase in herd immunity. Alternatively non-protective
immunity could actually facilitate the spread of virus, with pre-existing antibody
titres enabling survival and viral shedding in species such as swans that are
otherwise highly susceptible to infection [40].
Although our findings have important implications for bird populations, the
high proportion of sera for which exposure history was deemed ambiguous
illustrates the difficulty in using this technique at the individual bird level. Such
fine scale interpretation may be advanced through the development of more
sophisticated approaches to analyzing data arising from HI analyses. An analytical
technique that might be adapted for use in this area is antigenic cartography,
which creates a visual representation of antigenic relationships between antigens
and antibodies [28]. While this approach is more commonly used to examine
antigenic distinctiveness of viruses (e.g. in vaccine selection), it also has potential
in profiling the humoral immune response. Successful utilization would require
the careful selection of a panel of antigens, with sufficiently distinct antigenic
profiles to enable the placement of test sera in a manner that reflected exposure
history. Importantly, it would be necessary to verify that the humoral response of
different bird species was comparable to prevent anomalies from arising through
taxonomic differences.
In conclusion this study has demonstrated the potential of using HI assays to
identify populations of wild birds that have been exposed to HPAIV H5N1 strains.
This is complicated on an individual bird level by waning titres and repeated
infections. However, the technique may have utility in prioritizing populations for
HPAIV surveillance and development of risk management measures to prevent
exposure of the domestic poultry sector. Further experimental work to determine
how the avian immune system responds to repeated exposures of low and highly
pathogenic viruses would aid in interpreting future studies of this type, and in
understanding the impact of circulating antibodies on population-level immunity
and the epidemiology of HPAIV in wild birds.
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